Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 243

1.

NF-kappaB regulates androgen receptor expression and prostate cancer growth.

Zhang L, Altuwaijri S, Deng F, Chen L, Lal P, Bhanot UK, Korets R, Wenske S, Lilja HG, Chang C, Scher HI, Gerald WL.

Am J Pathol. 2009 Aug;175(2):489-99. doi: 10.2353/ajpath.2009.080727. Epub 2009 Jul 23.

PMID:
19628766
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

Jin RJ, Lho Y, Connelly L, Wang Y, Yu X, Saint Jean L, Case TC, Ellwood-Yen K, Sawyers CL, Bhowmick NA, Blackwell TS, Yull FE, Matusik RJ.

Cancer Res. 2008 Aug 15;68(16):6762-9. doi: 10.1158/0008-5472.CAN-08-0107.

PMID:
18701501
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.

Zerbini LF, Wang Y, Cho JY, Libermann TA.

Cancer Res. 2003 May 1;63(9):2206-15.

PMID:
12727841
[PubMed - indexed for MEDLINE]
Free Article
6.

Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).

Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC.

Prostate. 2006 Jul 1;66(10):1070-5.

PMID:
16637076
[PubMed - indexed for MEDLINE]
7.

Differential CARM1 expression in prostate and colorectal cancers.

Kim YR, Lee BK, Park RY, Nguyen NT, Bae JA, Kwon DD, Jung C.

BMC Cancer. 2010 May 13;10:197. doi: 10.1186/1471-2407-10-197.

PMID:
20462455
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.

Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.

Prostate. 2008 Mar 1;68(4):453-61. doi: 10.1002/pros.20723.

PMID:
18196538
[PubMed - indexed for MEDLINE]
10.

The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling.

Lamb LE, Zarif JC, Miranti CK.

Cancer Res. 2011 Apr 1;71(7):2739-49. doi: 10.1158/0008-5472.CAN-10-2745. Epub 2011 Feb 10.

PMID:
21310825
[PubMed - indexed for MEDLINE]
Free Article
11.

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.

Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.

Cancer Res. 2004 Oct 1;64(19):7156-68.

PMID:
15466214
[PubMed - indexed for MEDLINE]
Free Article
12.

Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha.

Ko S, Shi L, Kim S, Song CS, Chatterjee B.

Mol Endocrinol. 2008 Feb;22(2):273-86. Epub 2007 Nov 1.

PMID:
17975021
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?

Suh J, Rabson AB.

J Cell Biochem. 2004 Jan 1;91(1):100-17. Review.

PMID:
14689584
[PubMed - indexed for MEDLINE]
14.

PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.

Kaarbø M, Mikkelsen OL, Malerød L, Qu S, Lobert VH, Akgul G, Halvorsen T, Maelandsmo GM, Saatcioglu F.

Cell Oncol. 2010;32(1-2):11-27. doi: 10.3233/CLO-2009-0487.

PMID:
20203370
[PubMed - indexed for MEDLINE]
15.

PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.

Litvinov IV, Antony L, Dalrymple SL, Becker R, Cheng L, Isaacs JT.

Prostate. 2006 Sep 1;66(12):1329-38.

PMID:
16835890
[PubMed - indexed for MEDLINE]
16.

Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.

Mori A, Lehmann S, O'Kelly J, Kumagai T, Desmond JC, Pervan M, McBride WH, Kizaki M, Koeffler HP.

Cancer Res. 2006 Mar 15;66(6):3222-9.

PMID:
16540674
[PubMed - indexed for MEDLINE]
Free Article
17.

An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.

Paliouras M, Diamandis EP.

Biol Chem. 2008 Jun;389(6):773-80. doi: 10.1515/BC.2008.072.

PMID:
18627304
[PubMed - indexed for MEDLINE]
18.

Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.

Singh S, Shi Q, Bailey ST, Palczewski MJ, Pardee AB, Iglehart JD, Biswas DK.

Mol Cancer Ther. 2007 Jul;6(7):1973-82.

PMID:
17620428
[PubMed - indexed for MEDLINE]
Free Article
19.

Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.

Fan W, Yanase T, Morinaga H, Okabe T, Nomura M, Daitoku H, Fukamizu A, Kato S, Takayanagi R, Nawata H.

J Biol Chem. 2007 Mar 9;282(10):7329-38. Epub 2007 Jan 2.

PMID:
17202144
[PubMed - indexed for MEDLINE]
Free Article
20.

Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line.

Cinar B, Koeneman KS, Edlund M, Prins GS, Zhau HE, Chung LW.

Cancer Res. 2001 Oct 1;61(19):7310-7.

PMID:
11585771
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk